SIMPLY-SNAP: Evaluating the impact of a SIMPlified Layered consent process versus a conventional informed consent form on recruitment of potential participants to a large platform clinical trial: a pragmatic nested randomized controlled trial
We are enrolling potential SNAP trial participants to this sub-study to test out different consent processes and their impact on recruitment, participant understanding, and participant satisfaction.
This sub study is being conducted in Canada.
Lead Investigators: Dr Sean Ong, Prof Nick Daneman, Prof Steven Tong, Prof Joshua Davis, Dr Rob Mahar, A/Prof Todd Lee, Dr Emily McDonald
There are no additional blood tests, interventions, or follow-up required as part of this sub-study.
There will be additional survey questions assessing your understanding of the SNAP trial to determine how well you understood the information conveyed during the consent process.
There are no anticipated risks of participating in this sub-study.
All additional data collected as part of this sub-study will be de-identified and stored on the same secured database as the primary SNAP trial.
You can withdraw from the sub study at any time, just notify a member ofthe SNAP study team.
If you withdraw, we will keep any information wehave collected about you up until you withdraw.
Name: Dr Sean Ong (lead investigator)
Email: s.ong@mail.utoronto.ca
SNAP Trial
Profiling the genetic and epigenetic determinants that predispose to severe manifestations of Staphylococcus aureus bacteremia
Cell-free DNA is a Versatile Analyte to Monitor Complications and Guide Treatment Duration in Staphylococcus aureus Bacteremia
Derivation and Validation of Phenotypes of Staphylococcus aureus bloodstream infection, with Correlation with Outcome.
Pilot study for real-time sequencing of Staphylococcus aureus bloodstream isolates
Using a validated penicillin allergy risk prediction tool (Pen-FAST) in patients with a low risk penicillin allergy
Immunopathogenesis and pharmacogenomics of severe antibiotic hypersensitivity